Prediction of essential binding domains for the endocannabinoid N-arachidonoylethanolamine (AEA) in the brain cannabinoid CB1 receptor.
Δ9-tetrahydrocannabinol (Δ9-THC), the main active ingredient of Cannabis sativa (marijuana), interacts with the human brain cannabinoid (CB1) receptor and mimics pharmacological effects of endocannabinoids (eCBs) like N-arachidonylethanolamide (AEA). Due to its flexible nature of AEA structure with...
Main Author: | Joong-Youn Shim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0229879 |
Similar Items
-
Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans.
by: Ana B Fagundo, et al.
Published: (2013-01-01) -
The CB1Cannabinoid Receptor in the Brain
by: Allyn C. Howlett
Published: (1998-12-01) -
New Perspectives in the Studies on Endocannabinoid and Cannabis: Abnormal Behaviors Associate With CB1 Cannabinoid Receptor and Development of Therapeutic Application
by: Michihiro Fujiwara, et al.
Published: (2004-01-01) -
Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer’s disease
by: Alicia López, et al.
Published: (2018-05-01) -
Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes
by: Gemma Navarro, et al.
Published: (2018-06-01)